Investigating the Role of Ginger Tea ORAC Value in Hypertension Management

NCT ID: NCT06762834

Last Updated: 2025-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the antihypertensive effects of ginger tea. By examining its impact on blood pressure levels, this research aims to determine whether ginger tea can be an effective, natural adjunct to conventional hypertension treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This investigation will provide insights into its potential role in reducing the burden of hypertension and improving cardiovascular health

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ginger Tea

Group Type EXPERIMENTAL

Ginger tea

Intervention Type COMBINATION_PRODUCT

determine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.

Self Administered Tea

Group Type ACTIVE_COMPARATOR

self administred Ginger tea

Intervention Type COMBINATION_PRODUCT

To identify consumption and its correlation with blood pressure outcomes using a self- reported diary and periodic clinical assessments.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ginger tea

determine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.

Intervention Type COMBINATION_PRODUCT

self administred Ginger tea

To identify consumption and its correlation with blood pressure outcomes using a self- reported diary and periodic clinical assessments.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 30-65 years
* Diagnosed with stage 1 or stage 2 hypertension
* Not currently taking antihypertensive medication
* Willing to provide informed consent and adhere to study protocols.

Exclusion Criteria

* Pregnant or breastfeeding women
* Participants on antioxidant supplements or other herbal teas.
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Superior University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muhammad Naveed Babur

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azra Naheed Medical College, Superior University

Lahore, Punjab Province, Pakistan

Site Status

Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSAHS/Batch-Spring23/023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Green Tea Extract and Ginger
NCT07150533 COMPLETED NA
Ginger's Therapeutic Potential in Asthma
NCT03705832 COMPLETED EARLY_PHASE1